Geoffrey M. Parker is of Better Therapeutics, Inc.. Currently has a direct ownership of 1.03 Million shares of BTTX, which is worth approximately $0. The most recent transaction as insider was on Dec 18, 2023, when has been sold 3,750 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.03M
0% 3M change
0% 12M change
Total Value Held $0

Geoffrey M. Parker Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 18 2023
BUY
Grant, award, or other acquisition
-
3,750 Added 0.36%
1,031,805 Common Stock
Jul 27 2023
BUY
Open market or private purchase
$500,068 $0.73 p/Share
685,025 Added 39.99%
1,028,055 Common Stock
Apr 10 2023
BUY
Open market or private purchase
$248,484 $0.82 p/Share
303,030 Added 46.9%
343,030 Common Stock
Jun 13 2022
BUY
Open market or private purchase
$36,250 $1.45 p/Share
25,000 Added 38.46%
40,000 Common Stock
Mar 29 2022
BUY
Open market or private purchase
$32,250 $2.15 p/Share
15,000 Added 50.0%
15,000 Common Stock

Also insider at

TCDA
Tricida, Inc. Healthcare
CCXI
ChemoCentryx, Inc.
PRGO
PERRIGO Co plc Healthcare
ALLO
Allogene Therapeutics, Inc. Healthcare
GMP

Geoffrey M. Parker

San Carlos, CA

Track Institutional and Insider Activities on BTTX

Follow Better Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BTTX shares.

Notify only if

Insider Trading

Get notified when an Better Therapeutics, Inc. insider buys or sells BTTX shares.

Notify only if

News

Receive news related to Better Therapeutics, Inc.

Track Activities on BTTX